The IL-36 inhibitor is being explored for additional inflammatory skin conditions, aiming to expand treatment options for underserved patient groups.

The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and ...

Boehringer Ingelheim and LEO Pharma have signed an exclusive global license and transfer agreement to commercialize and ...

For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer ...

LEO Pharma A/S agreed to acquire the global rights for skin disease drug Spevigo from Boehringer Ingelheim GmbH, as the ...

Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

The trial aims to assess the safety and efficacy of tralokinumab 300mg administered biweekly as a single agent.

Pope Leo interrupted a two-week vacation on Wednesday to celebrate a special Mass exhorting Catholics to exercise care for ...

COMMENTARY: Despite what desires remain in Rome for full communion, it is a complete impossibility when the two most ...

LIMA, Peru (AP) — Pope Leo XIV has said there should be no tolerance in the Catholic Church for any type of abuse – sexual, spiritual or abuse of authority — and called for “transparent processes” to ...

The president is very unhappy with the federal judiciary and the Federalist Society.

Q1 2025 highlights LEO Pharma’s revenue increased by 10% year-on-year to DKK 3,373 million, and by 9% at constant exchange rates (CER).